These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12868860

  • 1. Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cells.
    Masunaga S, Takahashi A, Ohnishi K, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Ono K.
    Radiat Med; 2003; 21(3):120-7. PubMed ID: 12868860
    [Abstract] [Full Text] [Related]

  • 2. Dependency of repair of radiation-induced damage on p53 status and efficient inhibition of the repair with wortmannin treatment in vivo, with reference to the effect on intratumor quiescent cell population.
    Masunaga S, Takahashi A, Ohnishi K, Nagata K, Suzuki M, Kashino G, Kinashi Y, Ohnishi T, Ono K.
    Oncol Rep; 2007 Dec; 18(6):1589-96. PubMed ID: 17982649
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K.
    Anticancer Res; 2006 Dec; 26(2A):1261-70. PubMed ID: 16619533
    [Abstract] [Full Text] [Related]

  • 4. Effects of mild temperature hyperthermia and p53 status on the size of hypoxic fractions in solid tumors, with reference to the effect in intratumor quiescent cell populations.
    Masunaga S, Takahashi A, Ohnishi K, Ohnishi T, Nagata K, Suzuki M, Kinashi Y, Ono K.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):570-7. PubMed ID: 15380594
    [Abstract] [Full Text] [Related]

  • 5. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Ohnishi K, Takahashi A, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Ono K.
    Oncol Rep; 2005 Aug 01; 14(2):393-400. PubMed ID: 16012721
    [Abstract] [Full Text] [Related]

  • 6. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
    Masunaga S, Ono K, Akaboshi M, Takagaki M, Kinashi Y, Suzuki M, Abe M.
    Radiat Med; 1997 Aug 01; 15(1):37-43. PubMed ID: 9134583
    [Abstract] [Full Text] [Related]

  • 7. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S, Ono K, Hori H, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1999 Aug 01; 17(4):259-64. PubMed ID: 10510897
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
    Masunaga S, Ono K, Takahashi A, Ohnishi K, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Nagasawa H, Uto Y, Hori H.
    Cancer Sci; 2003 Jan 01; 94(1):125-33. PubMed ID: 12708486
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1998 Jan 01; 16(6):441-8. PubMed ID: 9929144
    [Abstract] [Full Text] [Related]

  • 10. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S, Sakurai Y, Suzuki M, Nagata K, Maruhashi A, Kinash Y, Ono K.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):920-7. PubMed ID: 15465210
    [Abstract] [Full Text] [Related]

  • 11. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S, Nagasawa H, Hiraoka M, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Anticancer Res; 2004 Nov 01; 24(5A):2975-83. PubMed ID: 15517904
    [Abstract] [Full Text] [Related]

  • 12. The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams.
    Masunaga SI, Uzawa A, Hirayama R, Matsumoto Y, Sakurai Y, Tanaka H, Tano K, Sanada Y, Suzuki M, Maruhashi A, Ono K.
    World J Oncol; 2015 Aug 01; 6(4):398-409. PubMed ID: 28983338
    [Abstract] [Full Text] [Related]

  • 13. Effects of p53 Status of Tumor Cells and Combined Treatment With Mild Hyperthermia, Wortmannin or Caffeine on Recovery From Radiation-Induced Damage.
    Masunaga SI, Tano K, Sanada Y, Suzuki M, Takahashi A, Ohnishi K, Ono K.
    World J Oncol; 2019 Jun 01; 10(3):132-141. PubMed ID: 31312280
    [Abstract] [Full Text] [Related]

  • 14. The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo.
    Masunaga S, Ando K, Uzawa A, Hirayama R, Furusawa Y, Koike S, Ono K.
    Acta Oncol; 2008 Jun 01; 47(6):1087-93. PubMed ID: 18607878
    [Abstract] [Full Text] [Related]

  • 15. Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells.
    Masunaga S, Ono K, Takahashi A, Ohnishi T, Kinashi Y, Takagaki M.
    Eur J Cancer; 2002 Mar 01; 38(5):718-27. PubMed ID: 11916556
    [Abstract] [Full Text] [Related]

  • 16. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells.
    Masunaga S, Ono K, Takahashi A, Sakurai Y, Ohnishi K, Kobayashi T, Kinashi Y, Takagaki M, Ohnishi T.
    Jpn J Cancer Res; 2002 Dec 01; 93(12):1366-77. PubMed ID: 12495477
    [Abstract] [Full Text] [Related]

  • 17. The Effect of p53 Status on Radio-Sensitivity of Quiescent Tumor Cell Population Irradiated With γ-Rays at Various Dose Rates.
    Masunaga SI, Kobayashi J, Tano K, Sanada Y, Suzuki M, Ono K.
    J Clin Med Res; 2018 Nov 01; 10(11):815-821. PubMed ID: 30344816
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of hexamethylenetetramine as an adjuvant to radiation and cisplatin in the treatment of solid tumors: its independency of p53 status.
    Masunaga S, Tano K, Nakamura J, Watanabe M, Kashino G, Takahashi A, Tanaka H, Suzuki M, Ohnishi K, Kinashi Y, Liu Y, Ohnishi T, Ono K.
    J Radiat Res; 2010 Nov 01; 51(1):27-35. PubMed ID: 19801892
    [Abstract] [Full Text] [Related]

  • 19. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K.
    Int J Hyperthermia; 2005 Jun 01; 21(4):305-18. PubMed ID: 16019857
    [Abstract] [Full Text] [Related]

  • 20. Effects of a heat shock protein inhibitor KNK437 on heat sensitivity and heat tolerance in human squamous cell carcinoma cell lines differing in p53 status.
    Ohnishi K, Takahashi A, Yokota S, Ohnishi T.
    Int J Radiat Biol; 2004 Aug 01; 80(8):607-14. PubMed ID: 15370972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.